PJ, June, Vol 298, No 7902

Pharmacists have a vital role to play in tackling misuse of prescription drugs by young people

As more young people turn from street drugs to prescription drugs for recreation or to enhance academic performance, pharmacists need to increase their vigilance when supplying medicines, either on prescription or over the counter, and be aware of medicines’ potential to end up on the black ma…

Another vote for the status quo at the Royal Pharmaceutical Society

The results of the recent national pharmacy board elections are in, but there is little change to report.…

Q&A: UK general election 2017: pharmacists react

The Pharmaceutical Journal interviews pharmacists from across the nation to get their thoughts on the results of the UK general election in June 2017.…

Pharmacists join the fight against hypertension

Some pharmacists are at the forefront of tackling high blood pressure by providing hypertension services within GP practices, community clinics and pharmacies. But to improve the prevention, early detection and management of the condition, these services need to be more widespread.…

Further 71 pharmacies deemed eligible for Pharmacy Access Scheme funding

NHS England has confirmed that an additional 71 pharmacies will now receive payments under the Pharmacy Access Scheme.…

Deaths: Bryan Holroyd Hartley

On 9 June 2017, Bryan Holroyd Hartley FRPharmS, aged 77, of Totnes, Devon. Mr Hartley registered with the Society in 1963. Mr Hartley was designated Fellow of the Royal Pharmaceutical Society of Great Britain in 1985. In 1995, he was appointed to the post of Chief Pharmaceutical Officer at the …

Deaths: Brian Ainley-Smith

On 3 May 2017, Brian Ainley-Smith, aged 87, of Bognor Regis, West Sussex. Mr Ainley-Smith registered with the Society in 1951 and left in 2008.…

Deaths: Adil Jafarali Nazarali

On 27 April 2017, Adil Jafarali Nazarali FRPharmS, aged 62, of Saskatoon, Saskatchewan, Canada. Dr Nazarali registered with the Society in 1978, and was designated Fellow of the Society in 2015.…

FDA requests first opioid removal from market after abuse sparks HIV outbreak

The US Food and Drug Administration has requested that a formulation of oxymorphone hydrochloride, marketed as Opana ER, be withdrawn from the market due to abuse, saying that the benefits of the product no longer outweigh the risks.…

The High Court verdict on community pharmacy cuts marks a new beginning, not the end

Ian Strachan from the National Pharmacy Association explains why pharmacists should not be disheartened by the High Court’s ruling on the judicial review against the funding cuts to community pharmacy in England.…